Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
21,331,464
Share change
-201,959
Total reported value
$412,748,829
Price per share
$19.35
Number of holders
57
Value change
-$7,253,468
Number of buys
33
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q4 2022

As of 31 Dec 2022, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,331,464 shares. The largest 10 holders included FMR LLC, Sofinnova Investments, Inc., Abingworth LLP, CITADEL ADVISORS LLC, Kynam Capital Management, LP, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, Octagon Capital Advisors LP, and Polar Asset Management Partners Inc.. This page lists 57 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.